Krav Maga: The Move We Did Not Plan For

Krav Maga is built for a simple reality: the person in front of you will not follow your plan.

You can train for different threats, but a real confrontation will not arrive as a perfect drill. The distance changes. The angle changes. The attacker reacts differently. The first response may not work exactly as anticipated.

That is why Krav Maga teaches techniques, but not as a script. It emphasizes simple, practical responses and common principles that can be applied when the situation changes.

One response may change the situation in front of you. What comes next depends on what is actually happening now, not on what was supposed to happen next.

Training prepares you for what might happen without assuming that reality will reproduce the scenario exactly.

That problem is familiar to anyone who has worked in clinical drug development.

Before a new drug is tested in patients, development teams make extensive plans. We predict how the drug will behave, decide how much to give, anticipate possible side effects, consider which patients may be most likely to benefit, and plan the studies that could come next.

Then the drug meets the patient.

It may behave differently than expected. Patients may need a different dose. Side effects we did not anticipate may appear. The drug may work better in one group of patients than another, sometimes not the group we originally expected. A test we thought would help us identify the right patients may prove less useful than hoped. Even our original explanation for why the drug should work may need to be reconsidered.

Each of those findings changes the situation in front of the development team.

And that is the critical point.

The next decision should respond to the situation that now exists, not simply follow the sequence that was planned before the first patient was treated.

A clinical trial has rules that must be followed. But clinical development is larger than a single trial. As evidence accumulates, the strategy can change.

That is where the Krav Maga mindset becomes useful.

The lesson is not simply to “be flexible.”

It is to prepare for change before you know exactly what that change will be.

Before the data arrive, we should not only ask what we expect to happen.

We should ask what we will do if it does not.

If patients tolerate the drug differently than expected, how should our dose strategy change?

If one group appears to benefit more than another, should development focus there?

If the test we hoped would identify the right patients does not work, what other way can we find them?

If the results challenge our original thinking, should the next study still look like the one we planned months earlier?

Having to make these decisions does not mean the original plan failed. It is what development is supposed to do as reality replaces prediction.

Krav Maga does not prepare someone to execute a sequence regardless of what the other person does. It prepares them to recognize what has changed and respond accordingly.

Clinical development should work the same way.

Plan carefully. Know the principles that should guide the next decision. Then let the evidence tell you which move comes next.

Good planning is not correctly predicting every move. It is knowing what will guide your decision when the move you expected never comes.

Krav Maga prepares people for that moment.

Drug development should too.

Because biology has never read the development plan.